Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl )-lH-pyrazol-l-yl)-3cyclopentylpropanenitrile

Details for Australian Patent Application No. 2008266182 (hide)

Owner Incyte Corporation

Inventors Rodgers, James D.; Arvanitis, Argyrios G.; Shi, Jack Guoen

Agent FB Rice

Pub. Number AU-A-2008266182

PCT Pub. Number WO2008/157207

Priority 60/943,695 13.06.07 US

Filing date 12 June 2008

Wipo publication date 24 December 2008

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2008/157207 Priority application(s): WO2008/157207

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008266183-Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl )-1H-pyrazol-1-yl)-3-cyclopentylpropane nitrile

2008266176-Solar module with a frame for mounting a solar panel